mechanisms of resistance to cdk4/6 inhibitors in triple negative breast cancer
Published 7 years ago • 136 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
0:50
investigating mechanisms of resistance to cdk4/6 inhibitors
-
1:08
overcoming resistance to cdk4/6 inhibitors in er breast cancer via ctdna
-
2:40
resistance to cdk4/6 inhibitors
-
4:50
expert report on tackling resistance to cdk4/6 inhibitors in er /her2-metastatic breast cancer
-
1:16
dr. sledge on mechanisms of resistance in breast cancer
-
5:01
cdk4/6 inhibitors: sequencing endocrine therapy for metastatic breast cancer
-
0:37
cdk4/6 inhibitors in her2-negative breast cancer based on phase iii monaleesa-7 trial
-
4:52
cdk4/6 inhibitors in hormone receptor-positive, her2-negative metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
3:14
tff1 and tff3 predict response to cdk4/6 inhibitors in breast cancer patients
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
4:48
ar triple negative breast cancer clinical trial
-
1:13
crosstalk between triple negative breast cancer and microenvironment | oncotarget
-
3:57
cdk4/6 inhibitors for metastatic breast cancer
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
20:19
expert discussion on cdk 4/6 inhibition in breast cancer
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer